发明公开
- 专利标题: OXO-SUBSTITUTED COMPOUND
-
申请号: US18309641申请日: 2023-04-28
-
公开(公告)号: US20230287009A1公开(公告)日: 2023-09-14
- 发明人: Toshio KANAI , Sachiko KOIKE , Takayuki FUKAYA , Shunichiro UESUGI , Shingo MIZUSHIMA , Hitoshi SUDA , Yuki MIZUKAMI , Yohei IKUMA , Toshiaki SUNAZUKA , Yoshihiko NOGUCHI
- 申请人: Sumitomo Pharma Co., Ltd. , THE KITASATO INSTITUTE
- 申请人地址: JP Osaka-shi
- 专利权人: Sumitomo Pharma Co., Ltd.,THE KITASATO INSTITUTE
- 当前专利权人: Sumitomo Pharma Co., Ltd.,THE KITASATO INSTITUTE
- 当前专利权人地址: JP Osaka-shi; JP Minato-ku
- 优先权: JP 18087761 2018.04.27
- 分案原申请号: US17050747 2020.10.26
- 主分类号: C07F5/02
- IPC分类号: C07F5/02 ; A61K45/06 ; A61P31/04 ; A61K31/407 ; A61K31/69
摘要:
Provided is a novel compound that has an excellent β-lactamase inhibitory effect. More specifically, provided is a compound represented by formula (1a), (1b) or (11) having an excellent β-lactamase inhibitory effect or a pharmaceutically acceptable salt thereof. By using this compound either in combination with a β-lactam drug or alone, a useful preventive or therapeutic agent for bacterial infections is provided. Also provided are useful preventive or therapeutic agents for treating various diseases with the combined use of the aforesaid compound and β-lactam drugs.
信息查询